Loss of cytoplasmic CDK1 predicts poor survival in human lung cancer and confers chemotherapeutic resistance.

The dismal lethality of lung cancer is due to late stage at diagnosis and inherent therapeutic resistance. The incorporation of targeted therapies has modestly improved clinical outcomes, but the identification of new targets could further improve clinical outcomes by guiding stratification of poor-...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Chunyu Zhang, Abdel G Elkahloun, Matthew Robertson, Joell J Gills, Junji Tsurutani, Joanna H Shih, Junya Fukuoka, M Christine Hollander, Curtis C Harris, William D Travis, Jin Jen, Phillip A Dennis
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Public Library of Science (PLoS) 2011-01-01
Saila:PLoS ONE
Sarrera elektronikoa:http://europepmc.org/articles/PMC3161069?pdf=render
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak